The importance of this mechanism to AD pathology is revealed in a study in APP/PS1 mice in which inhibition of CaN and NFAT binding in astrocytes is sufficient to reduce glial activation and Aβ production and improve cognitive performance and synaptic function (Furman et al., 2012). Here, NUP214 is linked to Alzheimer disease.